相关实验视频

Updated: Jul 1, 2026

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
04:56

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

在严重的COVID-19中评估康复性血疗法:一项回顾性队列研究

Masoud Moeini Taba1, Reza Eshraghi2, Maryam Zare Tutestani2

  • 1Department of Microbiology and Immunology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.

Journal of infection in developing countries
|January 26, 2025
PubMed
概括

康复性等离子体 (CP) 治疗对于严重的COVID-19患者来说是安全和潜在的有效. 这种被动免疫治疗在50名患者的研究中没有显示任何不良影响,为管理危急病例提供了宝贵的见解.

关键词:
在 COVID-19 疫情中,在CP疗法中,使用CP疗法.免疫接种 免疫接种 免疫接种

更多相关视频

Isolation, Characterization, and Proteomic Analysis of Plasma-Derived Extracellular Vesicles for Cardiovascular Biomarker Discovery05:30

Isolation, Characterization, and Proteomic Analysis of Plasma-Derived Extracellular Vesicles for Cardiovascular Biomarker Discovery

Published on: January 31, 2025

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah04:43

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah

Published on: June 24, 2025

相关概念视频

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
296